Abstract
Introduction
Parathyroid carcinoma (PC) is a rare neoplasm with a high rate of recurrence and an indolent course. It is frequently functional, causing nearly 1% of the cases of primary hyperparathyroidism (HPT), and in some cases, it may be complicated by brown tumors, mimicking bone metastases. Synchronous parathyroid and papillary thyroid carcinomas are rare.
Case report
We present a patient with HPT due to PC, misdiagnosed at first evaluation, which exhibited multiple hypermetabolic lytic lesions in the skeleton, suggesting bone metastases. Their regression after PTH reduction suggested the diagnosis of brown tumors due to severe HPT. Given the persistence of HPT, the patient underwent a number of neck surgeries, and a papillary thyroid microcarcinoma with a nodal metastasis was diagnosed. A genetic test discovered a previously unreported mutation of the CDC73 (HRPT2) gene, codifying for parafibromin and resulting in a premature stop codon (c.580A>Tp.Arg194). Because of the persistence of HPT, cinacalcet therapy was started in order to control hypercalcemia.
Conclusion
This is a very unusual patient with a newly discovered variant of the CDC73 gene and a phenotype characterized by recurrent PC, brown tumors, and N1a metastasized thyroid carcinoma. The present case confirms that PC may not exhibit clear malignant properties at first assessment, contributing to inadequate initial surgical treatment. Although infrequently, PC can be associated with papillary thyroid cancer. The diagnosis of brown tumor should be considered in patients with severe HPT and multiple destructive bone lesions mimicking metastases on PET/CT imaging.
Similar content being viewed by others
References
Marcocci C, Cetani F, Rubin MR et al (2008) Parathyroid carcinoma. J Bone Miner Res 23:1869–1880
Do Cao C, Aubert S, Trinel C et al (2015) Parathyroid carcinoma: diagnostic criteria, classification, evaluation. Ann Endocrinol 76:165–168
Cetani F, Pardi E, Marcocci C (2016) Update on parathyroid carcinoma. J Endocrinol Investig 39:595–606
Harari A, Waring A, Fernandez-Ranvier G et al (2011) Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab 96:3679–3686
Bassler T, Wong ET, Brynes RK (1993) Osteitis fibrosa cystica simulating metastatic tumor. An almost-forgotten relationship. Am J Clin Pathol 100:697–700
Goldfarb M, O'Neal P, Shih JL et al (2009) Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr Pract 15:463–468
Campennì A, Ruggeri RM, Sindoni A et al (2012) Parathyroid carcinoma as a challenging diagnosis: report of three cases. Hormones (Athens) 11:368–376
Wei CH, Harari A (2012) Parathyroid carcinoma: update and guidelines for management. Curr Treat Options in Oncol 13:11–23
Kassahun WT, Jonas S (2011) Focus on parathyroid carcinoma. Int J Surg 9:13–19
Makras P, Papapoulos SE (2009) Medical treatment of hypercalcaemia. Hormones (Athens) 8:83–95
Kerstens MN, de Vries R, Plukker JT et al (2014) Multiple skeletal lesions on FDG PET in severe primary hyperparathyroidism. Eur J Nucl Med Mol Imaging 41:182–183
Pai M, Park CH, Kim BS et al (1997) Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med 22:691–694
Kuwahara K, Izawa S, Murabe H et al (2007) Increased 18F-fluorodeoxyglucose uptake in a brown tumor in a patient with primary hyperparathyroidism. J Clin Endocrinol Metab 92:2408–2409
del Pozo C, García-Pascual L, Balsells M et al (2011) Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones (Athens) 10:326–331
Newey PJ, Bowl MR, Cranston T et al (2010) Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT)and parathyroid tumors. Hum Mutat 31:295–307
Yart A, Gstaiger M, Wirbelauer C et al (2005) The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 25:5052–5060
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Russo, M., Borzì, G., Ilenia, M. et al. Challenges in the treatment of parathyroid carcinoma: a case report. Hormones 18, 325–328 (2019). https://doi.org/10.1007/s42000-019-00104-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-019-00104-w